Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation

Haematologica

Volumn 89, Issue 6, 2004, Pages 761-762

  Asselta, Rosanna ^a   Bossone, Anna ^b   Iannoccone, Luigi ^c   Duga, Stefano ^a   Brancaccio, Vincenzo ^c   Margaglione, Maurizio ^b,d  

^a UNIVERSITY OF MILAN   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Activated protein C; Factor V Leiden; Mutation

Indexed keywords

ACTIVATED PROTEIN C; ASPARAGINE; BLOOD CLOTTING FACTOR 5; CIS ACTING ELEMENT; GLYCINE;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BLOOD GROUP; CASE REPORT; DNA SEQUENCE; FACTOR V GENE; FEMALE; GENE; GENE MUTATION; GENETIC TRANSFECTION; HAPLOTYPE; HETEROZYGOSITY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN SECRETION;

ACTIVATED PROTEIN C RESISTANCE; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHENOTYPE;

EID: 3042571425     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia. Part 1. Thromb Haemost 1996;76:651-62.
2. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002;8:308-21.
3. Zehnder JL, Jain M. Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency. Blood Coagul Fibrinolysis 1996;7:361-2.
4. Castaman G, Lunghi B, Missiaglia E, Bernardi F, Rodeghiero F. Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V. Br J Haematol 1997;99:257-61.
5. Guasch JF, Lensen RP, Bertina RM. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Thromb Haemost 1997;77:252-7.
6. van Wijk R, Montefusco MC, Duga S, Asselta R, van Solinge W, Malcovati M, et al. Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency. Br J Haematol 2001;114:871-4.
7. Dargaud Y, Trzeciak MC, Meunier S, Angei C, Pellechia D, Negrier C, Vinciguerra C. Two novel factor V null mutations associated with activated protein C resistance phenotype/genotype discrepancy. Br J Haematol 2003;123:342-5.
8. Pellequer JL, Gale AJ, Griffin JH, Getzoff ED. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains. Blood Cells Mol Dis 1998;24:448-61.
9. Becker J, Schwaab R, Moller-Taube A, Schwaab U, Schmidt W, Brackmann HH, et al. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet 1996;58:657-70.
10. Akkarapatumwong V, Oranwiroon S, Pung-amritt P, Treesucon A, Thanootarakul P, Veerakul G, et al. Mutations of the factor VIII gene in Thai hemophilia A patients. Hum Mutat 2000;15:117-8.